SEC Form 4 · accession 0000899243-19-004273
Whitehawk Therapeutics, Inc. · WHWK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin G. Peters
Officer — Chief Scientific Officer
Period of report
Feb 15, 2019
Accepted (ET)
Feb 20, 2019 · 4:52 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001422142
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $3.27 | Feb 15, 2019 | A | 125,000 | A | — | Feb 15, 2029 | Common Stock | 125,000 | 125,000 | D |
Explanation of responses
- F1Options exercisable as to 1/4th on the first anniversary of the grant date and an additional 1/48th monthly thereafter until the fourth anniversary of the grant date.